PLXP - ディペクシウム・ファ―マシュ―ティカルズ (PLx Pharma Inc.)

PLXPのニュース

   Insider Buys PLx Pharma Stock  2020/08/24 11:33:00 Benzinga
A Form 4 filing filed with the SEC on Monday, August 24 showed that OConnor Rita M bought 2,300 shares of PLx Pharma Inc. (NASDAQ: PLXP) at $3.77 on …
   PLx Pharma Inc. to Discuss 2020 Second Quarter Financial Results on August 14, 2020 Conference Call and Provide Business Update  2020/08/05 20:30:00 GlobeNewswire
SPARTA, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Discuss 2020 First Quarter Financial Results on May 15, 2020 Conference Call  2020/05/04 10:50:00 GlobeNewswire
SPARTA, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Present at Biotech Showcase 2020 | MarketScreener  2020/01/07 11:51:04 MarketScreener
SPARTA, N.J., Jan. 07, 2020 -- PLx Pharma Inc. , a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard™… | January 7, 2020
   PLx Pharma Provides Regulatory Update on VAZALORE  2020/01/06 14:48:12 Investing News Network
PLx Pharma announced that the US Food and Drug Administration (FDA) is providing clarification for the regulatory path forward for VAZALORE. The post PLx Pharma Provides Regulatory Update on VAZALORE appeared first on Investing News Network .
   PLx Pharma Inc. to Discuss 2020 First Quarter Financial Results on May 15, 2020 Conference Call  2020/05/04 10:50:00 GlobeNewswire
SPARTA, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Present at Biotech Showcase 2020 | MarketScreener  2020/01/07 11:51:04 MarketScreener
SPARTA, N.J., Jan. 07, 2020 -- PLx Pharma Inc. , a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard™… | January 7, 2020
   PLx Pharma Provides Regulatory Update on VAZALORE  2020/01/06 14:48:12 Investing News Network
PLx Pharma announced that the US Food and Drug Administration (FDA) is providing clarification for the regulatory path forward for VAZALORE. The post PLx Pharma Provides Regulatory Update on VAZALORE appeared first on Investing News Network .
   PLx Pharma Inc. Provides Regulatory Update on VAZALORE | MarketScreener  2020/01/06 11:51:01 MarketScreener
-- PLx Aligning with the FDA on Data Requirements for VAZALORE -- FDA Approves Labeling for 325 mg -- -- Expect to Launch VAZALORE in late 2020 -- SPARTA, N.J., Jan. 06, 2020 … | January 6, 2020
   Hedge Funds Have Never Been More Bullish On PLx Pharma Inc. (PLXP)  2019/11/30 16:39:56 Yahoo Finance
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through November 22nd. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 52% and 49% respectively. Our research shows that most of the stocks that smart money
   PLx Pharma Inc. to Discuss 2020 First Quarter Financial Results on May 15, 2020 Conference Call  2020/05/04 10:50:00 GlobeNewswire
SPARTA, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company…
   PLx Pharma Inc. to Present at Biotech Showcase 2020 | MarketScreener  2020/01/07 11:51:04 MarketScreener
SPARTA, N.J., Jan. 07, 2020 -- PLx Pharma Inc. , a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent-protected PLxGuard™… | January 7, 2020
   PLx Pharma Provides Regulatory Update on VAZALORE  2020/01/06 14:48:12 Investing News Network
PLx Pharma announced that the US Food and Drug Administration (FDA) is providing clarification for the regulatory path forward for VAZALORE. The post PLx Pharma Provides Regulatory Update on VAZALORE appeared first on Investing News Network .
   PLx Pharma Inc. Provides Regulatory Update on VAZALORE | MarketScreener  2020/01/06 11:51:01 MarketScreener
-- PLx Aligning with the FDA on Data Requirements for VAZALORE -- FDA Approves Labeling for 325 mg -- -- Expect to Launch VAZALORE in late 2020 -- SPARTA, N.J., Jan. 06, 2020 … | January 6, 2020
   Hedge Funds Have Never Been More Bullish On PLx Pharma Inc. (PLXP)  2019/11/30 16:39:56 Yahoo Finance
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through November 22nd. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 52% and 49% respectively. Our research shows that most of the stocks that smart money

calendar